Labcorp Holdings Inc. (LH)
LH Valuation Metrics
LH Stock Price Metrics
Last Close Price$266.161-Day Change+0.34%Market Cap (USD)$21.825B7D Return0.38%30D Return6.29%YTD Return5.76%52-Week High$293.7252-Week High Date10/20/2025Current vs High(9.38%)52-Week Low$241.8152-Week Low Date07/21/2025Current vs Low10.07%Avg Volume 1M631.8KBeta0.88Fair Value Price$387.20Margin of Safety45.48%
LH Dividend Metrics
Dividend Yield1.08%Avg Yield TTM1.08%Avg Yield 3Y1.06%CAGR TTM0.00%CAGR 3Y15.78%CAGR 5Y9.52%Payout Ratio27.32%Payout Avg 3Y38.50%Payout Avg 5Y-FCF Payout Ratio17.31%FCF Payout Avg 3Y22.86%FCF Payout Avg 5Y-Forward YOC 3Y18.14%Forward YOC 5Y118.79%Forward YOC 10Y13041.04%Ex-Date05/29/2026Payment Date06/11/2026Consec. Yearly Increases0
LH Growth Rate Metrics
Price CAGR TTM1.72%Price CAGR 3Y11.33%Price CAGR 5Y3.68%Total Return CAGR TTM2.80%Total Return CAGR 3Y12.68%Total Return CAGR 5Y4.75%Revenue CAGR TTM7.34%Revenue CAGR 3Y4.20%Revenue CAGR 5Y(1.58%)Net Income CAGR TTM28.83%Net Income CAGR 3Y(2.00%)Net Income CAGR 5Y(18.65%)EPS CAGR TTM18.57%EPS CAGR 3Y(9.11%)EPS CAGR 5Y(8.00%)FCF CAGR TTM20.14%FCF CAGR 3Y3.11%FCF CAGR 5Y(12.63%)Dividends CAGR TTM0.00%Dividends CAGR 3Y15.78%Dividends CAGR 5Y9.52%
LH Discounted Cash Flow Metrics
| Fair Value Price | $387.20 |
| Margin of Safety | 45.48% |
LH Revenue Metrics
LH PE Ratio Metrics
| PE Ratio | 23.57 |
| PE Ratio Avg TTM | 27.20 |
| PE Ratio Avg 3Y | 32.15 |
| Current VS TTM Avg | -13.33% |
| Current VS 3Y Avg | -26.68% |
| Current VS 5Y Avg | +0.74% |
LH PS Ratio Metrics
| PS Ratio | 1.56 |
| PS Ratio Avg TTM | 1.63 |
| PS Ratio Avg 3Y | 1.54 |
| Current VS TTM Avg | -4.30% |
| Current VS 3Y Avg | +1.15% |
| Current VS 5Y Avg | +6.07% |
LH PB Ratio Metrics
| PB Ratio | 2.53 |
| PB Ratio Avg TTM | 2.60 |
| PB Ratio Avg 3Y | 2.40 |
| Current VS TTM Avg | -2.79% |
| Current VS 3Y Avg | +5.46% |
| Current VS 5Y Avg | +12.83% |
LH Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 15.94 |
| PFCF Ratio Avg TTM | 17.42 |
| PFCF Ratio Avg 3Y | 19.61 |
| Current VS TTM Avg | -8.52% |
| Current VS 3Y Avg | -18.70% |
| Current VS 5Y Avg | +0.65% |
LH Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.84 |
| Debt/Equity Ratio Avg TTM | 0.87 |
| Debt/Equity Ratio Avg 3Y | 0.78 |
| Current VS TTM Avg | -3.45% |
| Current VS 3Y Avg | +7.69% |
| Current VS 5Y Avg | +13.00% |
LH PEG Ratio Metrics
| PEG Ratio | 1.28 |
| PEG Ratio Avg TTM | 0.79 |
| PEG Ratio Avg 3Y | 0.79 |
| Current VS TTM Avg | +62.03% |
| Current VS 3Y Avg | +62.03% |
| Current VS 5Y Avg | +169.47% |
LH FCF Yield
| FCF Yield | 6.27% |
| FCF Yield Avg TTM | 5.78% |
| FCF Yield Avg 3Y | 5.24% |
| Current VS TTM Avg | +8.49% |
| Current VS 3Y Avg | +19.67% |
| Current VS 5Y Avg | -12.76% |
LH Earnings Yield
| Earnings Yield | 4.24% |
| Earnings Yield Avg TTM | 3.71% |
| Earnings Yield Avg 3Y | 3.34% |
| Current VS TTM Avg | +14.21% |
| Current VS 3Y Avg | +26.81% |
| Current VS 5Y Avg | -29.96% |
LH EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 18.15 |
| Ev/Ebit Ratio Avg TTM | 21.97 |
| Ev/Ebit Ratio Avg 3Y | 26.25 |
| Current VS TTM Avg | -17.37% |
| Current VS 3Y Avg | -30.86% |
| Current VS 5Y Avg | -7.42% |
LH EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 13.73 |
| Ev/Ebitda Ratio Avg TTM | 14.69 |
| Ev/Ebitda Ratio Avg 3Y | 14.58 |
| Current VS TTM Avg | -6.52% |
| Current VS 3Y Avg | -5.85% |
| Current VS 5Y Avg | +17.21% |
LH EV/Assets Ratio Metrics
| Ev/Assets Ratio | 1.48 |
| Ev/Assets Ratio Avg TTM | 1.57 |
| Ev/Assets Ratio Avg 3Y | 1.46 |
| Current VS TTM Avg | -5.83% |
| Current VS 3Y Avg | +1.61% |
| Current VS 5Y Avg | +7.28% |
LH EV/Sales Ratio Metrics
| Ev/Sales Ratio | 2.00 |
| Ev/Sales Ratio Avg TTM | 2.09 |
| Ev/Sales Ratio Avg 3Y | 1.99 |
| Current VS TTM Avg | -4.46% |
| Current VS 3Y Avg | +0.28% |
| Current VS 5Y Avg | +6.48% |
LH Current Ratio Metrics
| Current Ratio | 1.42 |
| Current Ratio Avg TTM | 1.43 |
| Current Ratio Avg 3Y | 1.38 |
| Current VS TTM Avg | -0.70% |
| Current VS 3Y Avg | +2.71% |
| Current VS 5Y Avg | -6.48% |
LH Quick Ratio Metrics
| Quick Ratio | 1.23 |
| Quick Ratio Avg TTM | 1.27 |
| Quick Ratio Avg 3Y | 1.23 |
| Current VS TTM Avg | -2.77% |
| Current VS 3Y Avg | +0.41% |
| Current VS 5Y Avg | -10.00% |
LH ROIC Metrics
| ROIC | 7.39% |
| ROIC Avg 3Y | 5.64% |
| ROIC Avg 5Y | 7.56% |
| Current VS 3Y Avg | +31.09% |
| Current VS 5Y Avg | -2.23% |
| Current VS 10Y Avg | +3.49% |
LH Return on Assets Metrics
| ROA | 4.77 |
| ROA Avg TTM | 4.41 |
| ROA Avg 3Y | 4.42 |
| Current VS TTM Avg | +8.04% |
| Current VS 3Y Avg | +7.92% |
| Current VS 5Y Avg | -22.84% |
LH Return on Equity Metrics
| ROE | 10.17 |
| ROE Avg TTM | 9.71 |
| ROE Avg 3Y | 9.35 |
| Current VS TTM Avg | +4.68% |
| Current VS 3Y Avg | +8.74% |
| Current VS 5Y Avg | -20.79% |
LH Net Profit Margin Metrics
| Net Profit Margin | 6.28% |
| Net Profit Margin Avg TTM | 6.01% |
| Net Profit Margin Avg 3Y | 6.56% |
| Current VS TTM Avg | +4.58% |
| Current VS 3Y Avg | -4.23% |
| Current VS 5Y Avg | -32.06% |
Last Updated: Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter